Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05582538 |
| Title | Ceralasertib Followed by Durvalumab and Nab-paclitaxel Combination in mTNBC Patients (ATRiBRAVE) |
| Acronym | ATRiBRAVE |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | IFOM, The FIRC Institute of Molecular Oncology |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | ITA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Istituto Nazionale dei Tumori IRCCS | RECRUITING | Milano | Italy | Details | ||
| Azienda Ospedaliero Universitaria Maggiore della Carità | RECRUITING | Novara | Italy | Details | ||
| Istituto Oncologico Veneto IRCCS | RECRUITING | Padova | Italy | Details |